Rbf Capital, LLC Bausch Health Companies Inc. Transaction History

Rbf Capital, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $365,400 - $475,800	-60,000 Reduced 50.0%	60,000 $376,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $144,270 - $290,115	-31,500 Reduced 20.79%	120,000 $827,000
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $237,207 - $381,618	-11,100 Reduced 6.83%	151,500 $4.81 Million
Q4 2020 Feb 11, 2021	SELL	$15.31 - $21.12 $612,400 - $844,800	-40,000 Reduced 19.74%	162,600 $3.38 Million
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $3.01 Million - $4.08 Million	-202,600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $3.01 Million - $4.08 Million	202,600 New	202,600 $3.15 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $357,360 - $550,672	-26,849 Reduced 11.7%	202,600 $3.71 Million
Q1 2020 May 18, 2020	SELL	$12.98 - $30.25 $14,278 - $33,275	-1,100 Reduced 0.48%	229,449 $3.56 Million
Q4 2019 Feb 13, 2020	BUY	$18.89 - $31.89 $244,606 - $412,943	12,949 Added 5.95%	230,549 $6.9 Million
Q3 2019 Nov 13, 2019	BUY	$20.88 - $25.66 $313,200 - $384,900	15,000 Added 7.4%	217,600 $4.76 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $4.18 Million - $5.2 Million	202,600 New	202,600 $5.2 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Rbf Capital, LLC with notifications on news.